The SARS-CoV-2 lifecycle is dependent on the host metabolism machinery. It upregulates the PPARα and PPARγ genes in lipid metabolism, which supports the essential viral replication complex including lipid rafts and palmitoylation of viral protein. The use of PPAR ligands in SARS-CoV-2 infection may have positive effects by preventing cytokine storm and the ensuing inflammatory cascade. The inhibition of PPARα and PPARγ genes may alter the metabolism and may disrupt the lifecycle of SARS-CoV-2 and COVID-19 progression. In the present work, we have identified possible miRNAs targeting PPARα and PPARγ in search of modulators of PPARα and PPARγ genes expression. The identified miRNAs could possibly be viewed as new therapeutic targets against COVID-19 infection.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02648725.2022.2163867DOI Listing

Publication Analysis

Top Keywords

pparα pparγ
16
pparγ genes
12
identified mirnas
8
silico identification
4
identification micrornas
4
micrornas targeting
4
targeting pparα/γ
4
pparα/γ promising
4
promising therapeutics
4
therapeutics sars-cov‑2
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!